(AP Photo/Francisco Seco)

Phar­mas ral­ly to pro­tect em­ploy­ees in Ukraine, along with sup­port and do­na­tions to Rus­sia-in­vad­ed coun­try

As the bio­phar­ma in­dus­try mon­i­tors drug de­vel­op­ment and sup­ply dis­rup­tions that might stem from the Russ­ian in­va­sion of Ukraine, in­di­vid­ual phar­ma com­pa­nies are work­ing to en­sure the safe­ty of their em­ploy­ees in Ukraine — and in some cas­es, of­fer aid to the coun­try un­der siege.

Boehringer In­gel­heim said it is will con­tribute €2.5 mil­lion to hu­man­i­tar­i­an re­lief funds. A BI tweet on Sun­day read in part: “We con­demn the mil­i­tary ag­gres­sion against Ukraine,” and added that along with the fund­ing, it will “do every­thing we can to help our im­pact­ed col­leagues, their fam­i­lies and com­mu­ni­ties.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.